Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

paraquat dichloride 276g/l

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - agrostis gigantea top (unii: a5odf78epd) (agrostis gigantea top - unii:a5odf78epd) - agrostis gigantea top 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

United States - English - NLM (National Library of Medicine)

dna labs, inc. - agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), festuca pratensis pollen (unii: a0wfq8p6n1) (festuca pratensis pollen - unii:a0wfq8p6n1), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg, phleum pratense top - unii:s7pw24bx20), anthoxanthum odoratum pollen - allergies.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd -

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - neurology - indicated for the treatment of major depressive disorder in adult patients who have failed to receive satisfactory improvement from antidepressant medications.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - agrostis tenuis,anthoxanthum odoratum,arrhenatherum elatius,avena fatua,bromus inermis,cynodon dactylon,dactylis glomerata,festuca elatior,holcus lanatus,lolium perenne,phleum pratense,poa pratensis -

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - agrostis tenuis,anthoxanthum odoratum,arrhenatherum elatius,avena fatua,bromus inermis,cynodon dactylon,dactylis glomerata,festuca elatior,holcus lanatus,lolium perenne,phleum pratense,poa pratensis -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cropsure pty ltd - azoxystrobin - suspension concentrate - azoxystrobin pyrimidine active 250.0 g/l - fungicide

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 20000 [bau] in 1 ml - indicated use of allergenic extracts is for the diagnosis and treatment (hyposensitization therapy) of patients who experience allergic symptoms due to exposure to grass pollen and who exhibit type i skin sensitivity when tested to those specific allergens. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants in situations where the offending allergen cannot be avoided. for previously untreated patients, prior to the initiation of therapy, clinical sensitivity to the standardized grass pollen extract should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. 10,000 bau/ml extracts are indicated for percutaneous testing. if negative, the 100,000 bau/ml dose may be used. availability of 10,000 and 100,000 bau/ml dosages facilitate safe

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 1000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w